Lysosomotropic behavior of adrenergic antagonists in interactions with human neutrophils.

Autonomic neurohormones affect the secretory activity of neutrophils by modulating release of lysosomal enzymes in response to immunologic stimuli. Autonomic agents are also weak bases which might modify cell function by accumulating in the acidic interior of the lysosome, in addition to their receptor-mediated activity. We examined the association of the beta-adrenergic antagonist [3H]dihydroalprenolol with human neutrophils and lysosome and membrane fractions derived from neutrophils, and the subcellular distribution of the photoaffinity-labeled beta-adrenergic ligand [3H]azidobenzylcarazolol after incubation with intact cells. Isolated neutrophil lysosomes accumulated significantly more [3H]dihydroalprenolol than isolated membrane preparations. Decreasing the transmembrane pH gradient markedly reduced [3H]dihydroalprenolol accumulation by intact cells or lysosomes but not by membranes. Since [3H]dihydroalprenolol accumulated by intact cells remained rapidly exchangeable, the photoaffinity ligand [3H]azidobenzylcarazolol was used to assess ligand distribution after association with whole cells. After cell disruption, 18.5 +/- 1.3% of this ligand appeared in the lysosome fraction as compared to 2.2 +/- 0.6% in the membrane fraction. The secretagogue phorbol myristate acetate caused release of the ligand as well as lysosomal enzymes from cells. These findings suggest that there is significant pH-dependent lysosomal accumulation of beta-antagonists. This lysosomotropic interaction may be important both as it affects the sequestration and redistribution of the drugs, and as it might in some circumstances affect host defense functions of the neutrophil.

[1]  M. Klempner,et al.  Alkalinizing the intralysosomal pH inhibits degranulation of human neutrophils. , 1983, The Journal of clinical investigation.

[2]  S. Galant,et al.  Binding and functional characteristics of beta adrenergic receptors in the intact neutrophil. , 1981, The Journal of laboratory and clinical medicine.

[3]  I. Wilson,et al.  The uptake of amines by polymorphonuclear leukocytes. , 1981, Biochimica et biophysica acta.

[4]  M. S. Ching,et al.  A carrier‐protein receptor is not a prerequisite for avid hepatic elimination of highly bound compounds: A study of propranolol elimination by the isolated perfused rat liver , 1985, Hepatology.

[5]  M. M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[6]  J. Knowles,et al.  [8] Photoaffinity labeling , 1977 .

[7]  Galant Sp,et al.  Demonstration of beta-2 adrenergic receptors of high coupling efficiency in human neutrophil sonicates. , 1980 .

[8]  T. Gaffney,et al.  Depolarization‐induced release of propranolol and atenolol from rat cortical synaptosomes , 1985, British journal of pharmacology.

[9]  M. Klempner,et al.  Internal pH of human neutrophil lysosomes , 1982, FEBS letters.

[10]  J. Powell,et al.  The Influence of H2‐Receptor Antagonists on Steady‐State Concentrations of Propranolol and 4‐Hydroxypropranolol , 1984, Journal of clinical pharmacology.

[11]  K. Meier,et al.  Uptake of L-[propyl-2,3-3H]dihydroalprenolol by intact HeLa cells. , 1984, Biochimica et biophysica acta.

[12]  L. Endrenyi,et al.  Plasma Concentration‐Response Relationships of Two Formulations of Propranolol , 1985, Journal of clinical pharmacology.

[13]  H. Motulsky,et al.  Transient Catecholamine Modulation of Neutrophil Activation: Kinetic and Intracellular Aspects of Isoproterenol Action , 1986, Journal of leukocyte biology.

[14]  I. Wilson,et al.  The beta-adrenergic receptor of live human polymorphonuclear leukocytes. , 1980, The Journal of biological chemistry.

[15]  M. Caron,et al.  Photoaffinity labeling of the beta-adrenergic receptor. , 1981, The Journal of biological chemistry.

[16]  M. Vore,et al.  Cardiovascular and pharmacokinetic consequences of combined administration of verapamil and propranolol in dogs. , 1985, The American journal of cardiology.

[17]  M. Klempner,et al.  Clindamycin uptake by human neutrophils. , 1981, The Journal of infectious diseases.

[18]  Klempner,et al.  Inhibition of neutrophil oxidative metabolism by lysosomotropic weak bases , 1986 .

[19]  A. Bøyum,et al.  Isolation of mononuclear cells and granulocytes from human blood. , 1968 .

[20]  M. Klempner,et al.  Neutrophil plasma membranes. I. High-yield purification of human neutrophil plasma membrane vesicles by nitrogen cavitation and differential centrifugation , 1980, The Journal of cell biology.

[21]  J. Mortensen,et al.  ORAL AND TOPICAL ADRENERGIC β‐RECEPTOR BLOCKERS IN GLAUCOMA TREATMENT A Multicenter Study , 1984, Acta ophthalmologica.

[22]  P. Tulkens,et al.  Commentary. Lysosomotropic agents. , 1974, Biochemical pharmacology.